Exact Mass: 552.3536194
Exact Mass Matches: 552.3536194
Found 410 metabolites which its exact mass value is equals to given mass value 552.3536194
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Pandamine
Triterpenoid
Triterpenoid is a byproduct from squalene 2,3-oxide decomposition. Squalene is a precursor to sterol biosynthesis. Terpenes are derived biosynthetically from units of isoprene, which has the molecular formula C5H8. The basic molecular formulas of terpenes are multiples of that, (C5H8)n where n is the number of linked isoprene units. This is called the isoprene rule or the C5 rule. The isoprene units may be linked together "head to tail" to form linear chains or they may can be arranged to form rings. One can consider the isoprene unit as one of natures preferred building blocks. [HMDB] Triterpenoid is a byproduct from squalene 2,3-oxide decomposition. Squalene is a precursor to sterol biosynthesis. Terpenes are derived biosynthetically from units of isoprene, which has the molecular formula C5H8. The basic molecular formulas of terpenes are multiples of that, (C5H8)n where n is the number of linked isoprene units. This is called the isoprene rule or the C5 rule. The isoprene units may be linked together "head to tail" to form linear chains or they may can be arranged to form rings. One can consider the isoprene unit as one of natures preferred building blocks.
Elastin
Furohyperforin
Constituent of Hypericum perforatum (St. Johns Wort). Furohyperforin is found in tea, alcoholic beverages, and herbs and spices. Furohyperforin is found in alcoholic beverages. Furohyperforin is a constituent of Hypericum perforatum (St. Johns Wort).
Oxepahyperforin
Oxepahyperforin is found in alcoholic beverages. Oxepahyperforin is a constituent of Hypericum perforatum (St. Johns Wort)
Cyclopassifloic acid E
Cyclopassifloic acid E is found in fruits. Cyclopassifloic acid E is a constituent of Passiflora edulis (passion fruit) Constituent of Passiflora edulis (passion fruit). Cyclopassifloic acid E is found in fruits.
8-Hydroxyhyperforin 8,1-hemiacetal
8-Hydroxyhyperforin 8,1-hemiacetal is found in alcoholic beverages. 8-Hydroxyhyperforin 8,1-hemiacetal is a constituent of Hypericum perforatum (St. Johns Wort).
Lithocholate 3-O-glucuronide
Analysis of sequential bile samples by thin-layer chromatography (TLC) demonstrated that lithocholic acid glucuronide was present in bile throughout the course of the experiments and that its secretion rate paralleled that of total isotope secretion. Initial confirmation of the identity of this metabolite was obtained by the recovery of labeled lithocholic acid after beta-glucuronidase hydrolysis of bile samples. Glucuronates; Lithocholic Acid. Analysis of sequential bile samples by thin-layer chromatography (TLC) demonstrated that lithocholic acid glucuronide was present in bile throughout the course of the experiments and that its secretion rate paralleled that of total isotope secretion. Initial confirmation of the identity of this metabolite was obtained by the recovery of labeled lithocholic acid after beta-glucuronidase hydrolysis of bile samples. D005765 - Gastrointestinal Agents > D001647 - Bile Acids and Salts D005765 - Gastrointestinal Agents > D002793 - Cholic Acids
Arbekacin
Arbekacin is only found in individuals that have used or taken this drug. It is an semisynthetic aminoglycoside antibiotic. Often used for treatment of multi-resistant bacterial infection such as methicillin-resistant Staphylococcus aureus (MRSA). Amikacin is also nephrotoxic and ototoxic.Aminoglycosides, such as Arbekacin, inhibit protein synthesis in susceptible bacteria by irreversibly binding to bacterial 30S and 16S ribosomal subunits. Specifically Arbekacin binds to four nucleotides of 16S rRNA and a single amino acid of protein S12. This interferes with decoding site in the vicinity of nucleotide 1400 in 16S rRNA of 30S subunit. This region interacts with the wobble base in the anticodon of tRNA. This leads to misreading of mRNA so incorrect amino acids are inserted into the polypeptide leading to nonfunctional or toxic peptides and the breakup of polysomes into nonfunctional monosomes. J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01G - Aminoglycoside antibacterials C784 - Protein Synthesis Inhibitor > C2363 - Aminoglycoside Antibiotic D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents C254 - Anti-Infective Agent > C258 - Antibiotic
Nonadecylresorcinol glucuronide
Nonadecylresorcinol glucuronide is an alkylresorcinol metabolite. It is a potential plasma biomarker of whole grain intake (PMID: 25527657).
Elastin
Gilteritinib
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01E - Protein kinase inhibitors C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor
Lithocholic acid glucuronide
D005765 - Gastrointestinal Agents > D001647 - Bile Acids and Salts D005765 - Gastrointestinal Agents > D002793 - Cholic Acids
Rehmannic acid
DG(8:0/PGE2/0:0)
DG(8:0/PGE2/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(8:0/PGE2/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(PGE2/8:0/0:0)
DG(PGE2/8:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(PGE2/8:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(8:0/0:0/PGE2)
DG(8:0/0:0/PGE2) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(PGE2/0:0/8:0)
DG(PGE2/0:0/8:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(8:0/PGD2/0:0)
DG(8:0/PGD2/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(8:0/PGD2/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(PGD2/8:0/0:0)
DG(PGD2/8:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(PGD2/8:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(8:0/0:0/PGD2)
DG(8:0/0:0/PGD2) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(PGD2/0:0/8:0)
DG(PGD2/0:0/8:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(8:0/20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/0:0)
DG(8:0/20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(8:0/20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/8:0/0:0)
DG(20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/8:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/8:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(8:0/0:0/20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S))
DG(8:0/0:0/20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/0:0/8:0)
DG(20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/0:0/8:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
3,9-epoxy-20alphaF-(2-ethyl-4-methyl-pyrrole-3-carbonyloxy)-25-methyl-(5beta)-14beta,13-[1]oxa[4]azapentano-18-nor-pregna-7,16-diene-3beta,11alpha-diol|Batrachotoxinin A-20-(2-ethyl-4-methyl-pyrrol-3-carboxylat) od. Homobatrachotoxin od. Isobatrachotoxin|homobatrachotoxin|O20-(2-ethyl-4-methyl-pyrrole-3-carbonyl)-batrachotoxinin-A
(19E,19E)-18,18-dideoxy-22,22-dinor-toxiferin-I|(19E,19E)-18,18-Didesoxy-22,22-dinor-toxiferin-I|Bisnordihydrotoxiferine|bisnordihydroxiferin|nordihydrotoxiferine
3alpha-Angeloyloxy-2beta,15-dihydroxy-ent-labd-7-ene-2-O-beta-fucopyranoside
(8E,12E,14E)-7-acetoxy-3,6,17,21-tetrahydroxy-6,10,12,16,20-pentamethyl-18,19-epoxytricosa-8,12,14-trien-11-olide
6-Benzoyl-(2alpha,3beta,5alpha,6beta,25S)-Spirostane-2,3,6-triol
20S,23R,24R-23-chloro-20,24-epoxy-dammarane-3alpha,24,25-triol 3-acetate
(8E,12E,14E)-7-acetoxy-3,6,16,21-tetrahydroxy-6,10,12,16,20-pentamethyl-18,19-epoxytricosa-8,12,14-trien-11-olide|(8E,12E,14E)-7-acetoxy-6,10,12,16,20-pentamethyl-3,6,16,21-tetrahydroxy-18,19-epoxytricosa-8,12,14-trien-11-olide|epi-(8E,12E,14E)-7-acetoxy-3,6,16,21-tetrahydroxy-6,10,12,16,20-pentamethyl-18,19epoxytricosa-8,12,14-trien-11-olide
2-(beta-D-glucopyranosyloxy)-3,16-dihydroxy-4,4,9,14-tetramethyl-19-norpregn-5-en-20-one
(22beta)-22-{[3-methyl-1-oxobut-2-enyl]oxy}-3-oxoolean-12-en-28-oic acid|lantadane A
(1S,2R,3S,4R,5R,6S,8E,11S,12R,13S,14S)-3-acetoxy-2,12-dibutanoyloxycladiell-8-ene-4,11-diol
(22beta)-22-{[(2Z)-2-methyl-1-oxobut-2-enyl]oxy}-3-oxoolean-12-en-28-oic acid|lantadane A
3beta,27-dihydroxyolean-12-en-28-oic acid 3-sulfate ester
11-(2-Methylbutanoyl),12-benzoyl-Tenacigenin B|11alpha-O-2-methylbutyryl-12beta-O-benzoyltenacigenin B
2,3-DIACETOXY-7,8-EPOXY-24,29-DINOR-1,3,5-FRIEDELATRIENE-20-CARBOXYLIC ACID
His Ile Lys Arg
9SK62WCU1W
Rehmannic acid is a natural product found in Lantana camara, Combretum sundaicum, and other organisms with data available.
Furohyperforin
(2S,3S,4S,5R,6R)-6-(((3R,5R,8R,9S,10S,13R,14S,17R)-17-((R)-4-carboxybutan-2-yl)-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-3-yl)oxy)-3,4,5-trihydroxytetrahydro-2H-pyran-2-carboxylic acid
Arbekacin
J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01G - Aminoglycoside antibacterials A kanamycin that is kanamycin B bearing an N-(2S)-4-amino-2-hydroxybutyryl group on the aminocyclitol ring. C784 - Protein Synthesis Inhibitor > C2363 - Aminoglycoside Antibiotic D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents C254 - Anti-Infective Agent > C258 - Antibiotic
Phe Lys Lys Met
Phe Lys Met Lys
Phe Met Lys Lys
His Ile Gln Arg
His Ile Arg Lys
His Ile Arg Gln
His Lys Ile Arg
His Lys Leu Arg
His Lys Arg Ile
His Lys Arg Leu
His Leu Lys Arg
His Leu Gln Arg
His Leu Arg Lys
His Leu Arg Gln
His Gln Ile Arg
His Gln Leu Arg
His Gln Arg Ile
His Gln Arg Leu
His Arg Ile Lys
His Arg Ile Gln
His Arg Lys Ile
His Arg Lys Leu
His Arg Leu Lys
His Arg Leu Gln
His Arg Gln Ile
His Arg Gln Leu
Ile His Lys Arg
Ile His Gln Arg
Ile His Arg Lys
Ile His Arg Gln
Ile Lys His Arg
Ile Lys Arg His
Ile Gln His Arg
Ile Gln Arg His
Ile Arg His Lys
Ile Arg His Gln
Ile Arg Lys His
Ile Arg Gln His
Lys Phe Lys Met
Lys Phe Met Lys
Lys His Ile Arg
Lys His Leu Arg
Lys His Arg Ile
Lys His Arg Leu
Lys Ile His Arg
Lys Ile Arg His
Lys Lys Phe Met
Lys Lys Met Phe
Lys Leu His Arg
Lys Leu Arg His
Lys Met Phe Lys
Lys Met Lys Phe
Lys Arg His Ile
Lys Arg His Leu
Lys Arg Ile His
Lys Arg Leu His
Leu His Lys Arg
Leu His Gln Arg
Leu His Arg Lys
Leu His Arg Gln
Leu Lys His Arg
Leu Lys Arg His
Leu Gln His Arg
Leu Gln Arg His
Leu Arg His Lys
Leu Arg His Gln
Leu Arg Lys His
Leu Arg Gln His
Met Phe Lys Lys
Met Lys Phe Lys
Met Lys Lys Phe
Gln His Ile Arg
Gln His Leu Arg
Gln His Arg Ile
Gln His Arg Leu
Gln Ile His Arg
Gln Ile Arg His
Gln Leu His Arg
Gln Leu Arg His
Gln Arg His Ile
Gln Arg His Leu
Gln Arg Ile His
Gln Arg Leu His
Arg His Ile Lys
Arg His Ile Gln
Arg His Lys Ile
Arg His Lys Leu
Arg His Leu Lys
Arg His Leu Gln
Arg His Gln Ile
Arg His Gln Leu
Arg Ile His Lys
Arg Ile His Gln
Arg Ile Lys His
Arg Ile Gln His
Arg Lys His Ile
Arg Lys His Leu
Arg Lys Ile His
Arg Lys Leu His
Arg Leu His Lys
Arg Leu His Gln
Arg Leu Lys His
Arg Leu Gln His
Arg Gln His Ile
Arg Gln His Leu
Arg Gln Ile His
Arg Gln Leu His
8-Hydroxyhyperforin 8,1-hemiacetal
Oxepahyperforin
Cyclopassifloic acid E
ST 24:1;O3;GlcA
D005765 - Gastrointestinal Agents > D001647 - Bile Acids and Salts D005765 - Gastrointestinal Agents > D002793 - Cholic Acids
2-(16-isoquinolin-2-ium-2-ylhexadecyl)isoquinolin-2-ium,dichloride
C34H46Cl2N2 (552.3037856000001)
2-{bis[3-(dimethylamino)propyl]amino}-4-[(3-methyl-1,3-benzothiazol-2(3H)-ylidene)methyl]-1-phenylquinolinium
Gilteritinib
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01E - Protein kinase inhibitors C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor
8-Hydroxy-4-methyl-1,5,7-tris(3-methylbut-2-enyl)-4-(4-methylpent-3-enyl)-3-(2-methylpropanoyl)-9-oxatricyclo[5.2.1.03,8]decane-2,10-dione
20-Deoxo-20-dihydro-12,13-deepoxyrosamicin
C31H54NO7+ (552.3900074000001)
diaminomethylidene-[4-[[5-[(E)-3-[4-(diaminomethylideneazaniumyl)butylamino]-3-oxoprop-1-enyl]-2-(4-hydroxyphenyl)-2,3-dihydro-1-benzofuran-3-carbonyl]amino]butyl]azanium
1-O-Octadecyl-2-O-acetyl-sn-glycero-3-phosphocholine
2,2,6a,6b,9,9,12a-heptamethyl-4-[(E)-2-methylbut-2-enoyl]oxy-10-oxo-3,4,5,6,6a,7,8,8a,11,12,13,14b-dodecahydro-1H-picene-4a-carboxylic acid
Lithocholic acid glucuronide
D005765 - Gastrointestinal Agents > D001647 - Bile Acids and Salts D005765 - Gastrointestinal Agents > D002793 - Cholic Acids
O-(1-O-Octadecyl-2-O-acetyl-L-glycero-3-phospho)choline
1-[(2S,3R)-2-[[cyclohexylmethyl(methyl)amino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-3-(4-methoxyphenyl)urea
[O-(1-O-Hexadecyl-2-O-butanoyl-L-glycero-3-phospho)choline]anion
1-[(2R,3R)-2-[[cyclohexylmethyl(methyl)amino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-3-(4-methoxyphenyl)urea
1-[(2S,3S)-2-[[cyclohexylmethyl(methyl)amino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-3-(4-methoxyphenyl)urea
1-[(2R,3S)-2-[[cyclohexylmethyl(methyl)amino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-3-(4-methoxyphenyl)urea
[O-(1-O-Hexadecanoyl-2-O-propanoyl-L-glycero-3-phospho)choline]anion
2-[(2-Butanoyloxy-3-hexadecoxypropoxy)-hydroxyphosphoryl]oxyethyl-trimethylazanium
2,3-dihydroxypropyl [3-[(Z)-docos-13-enoxy]-2-hydroxypropyl] hydrogen phosphate
[3-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-2-hydroxypropyl] (Z)-henicos-11-enoate
[2-[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoyl]oxy-3-hydroxypropyl] (4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoate
[1-[(2-heptanoyloxy-3-hydroxypropoxy)-hydroxyphosphoryl]oxy-3-hydroxypropan-2-yl] (Z)-tridec-9-enoate
[1-[(2-butanoyloxy-3-hydroxypropoxy)-hydroxyphosphoryl]oxy-3-hydroxypropan-2-yl] (Z)-hexadec-9-enoate
[1-[(2-hexanoyloxy-3-hydroxypropoxy)-hydroxyphosphoryl]oxy-3-hydroxypropan-2-yl] (Z)-tetradec-9-enoate
[1-hydroxy-3-[hydroxy-(3-hydroxy-2-pentanoyloxypropoxy)phosphoryl]oxypropan-2-yl] (Z)-pentadec-9-enoate
[1-[(2-acetyloxy-3-hydroxypropoxy)-hydroxyphosphoryl]oxy-3-hydroxypropan-2-yl] (Z)-octadec-9-enoate
[1-hydroxy-3-[hydroxy-(3-hydroxy-2-propanoyloxypropoxy)phosphoryl]oxypropan-2-yl] (Z)-heptadec-9-enoate
[1-butanoyloxy-3-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxypropan-2-yl] (Z)-hexadec-9-enoate
[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-propanoyloxypropan-2-yl] (Z)-heptadec-9-enoate
[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-hexanoyloxypropan-2-yl] (Z)-tetradec-9-enoate
[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-heptanoyloxypropan-2-yl] (Z)-tridec-9-enoate
[1-acetyloxy-3-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxypropan-2-yl] (Z)-octadec-9-enoate
[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-pentanoyloxypropan-2-yl] (Z)-pentadec-9-enoate
2-[(2-Decanoyloxy-3-nonanoyloxypropoxy)-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[Hydroxy-(2-hydroxy-3-icosanoyloxypropoxy)phosphoryl]oxyethyl-trimethylazanium
2-[(2-Hexadecanoyloxy-3-propanoyloxypropoxy)-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[Hydroxy-(3-hydroxy-2-icosanoyloxypropoxy)phosphoryl]oxyethyl-trimethylazanium
2-[Hydroxy-(3-octanoyloxy-2-undecanoyloxypropoxy)phosphoryl]oxyethyl-trimethylazanium
[2-[(5E,7E,9E,11E,13E)-hexadeca-5,7,9,11,13-pentaenoyl]oxy-3-hydroxypropyl] (9E,11E,13E)-hexadeca-9,11,13-trienoate
[2-[(7E,9E,11E,13E)-hexadeca-7,9,11,13-tetraenoyl]oxy-3-hydroxypropyl] (7E,9E,11E,13E)-hexadeca-7,9,11,13-tetraenoate
[1-carboxy-3-[3-[(4E,7E)-deca-4,7-dienoyl]oxy-2-[(E)-undec-4-enoyl]oxypropoxy]propyl]-trimethylazanium
C31H54NO7+ (552.3900074000001)
[1-[(5E,7E,9E,11E,13E)-hexadeca-5,7,9,11,13-pentaenoyl]oxy-3-hydroxypropan-2-yl] (9E,11E,13E)-hexadeca-9,11,13-trienoate
[1-carboxy-3-[2-[(4E,7E)-deca-4,7-dienoyl]oxy-3-[(E)-undec-4-enoyl]oxypropoxy]propyl]-trimethylazanium
C31H54NO7+ (552.3900074000001)
2-[(3-Acetyloxy-2-heptadecanoyloxypropoxy)-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[(2-Hexanoyloxy-3-tetradecoxypropoxy)-hydroxyphosphoryl]oxyethyl-trimethylazanium
[1-carboxy-3-[2-[(9Z,12Z,15Z)-octadeca-9,12,15-trienoyl]oxy-3-propanoyloxypropoxy]propyl]-trimethylazanium
C31H54NO7+ (552.3900074000001)
2-[Hydroxy-(3-pentanoyloxy-2-tetradecanoyloxypropoxy)phosphoryl]oxyethyl-trimethylazanium
2-[(2-Dodecanoyloxy-3-heptanoyloxypropoxy)-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[(3-Hexanoyloxy-2-tridecanoyloxypropoxy)-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[(3-Butanoyloxy-2-pentadecanoyloxypropoxy)-hydroxyphosphoryl]oxyethyl-trimethylazanium
[1-carboxy-3-[2-[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoyl]oxy-3-pentanoyloxypropoxy]propyl]-trimethylazanium
C31H54NO7+ (552.3900074000001)
2-[(2-Dodecanoyloxy-3-octoxypropoxy)-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[Hydroxy-(3-pentadecoxy-2-pentanoyloxypropoxy)phosphoryl]oxyethyl-trimethylazanium
2-[(2-Heptanoyloxy-3-tridecoxypropoxy)-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[(3-Heptadecoxy-2-propanoyloxypropoxy)-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[Hydroxy-(3-nonoxy-2-undecanoyloxypropoxy)phosphoryl]oxyethyl-trimethylazanium
2-[Hydroxy-(2-nonanoyloxy-3-undecoxypropoxy)phosphoryl]oxyethyl-trimethylazanium
2-[(3-Dodecoxy-2-octanoyloxypropoxy)-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[(2-Decanoyloxy-3-decoxypropoxy)-hydroxyphosphoryl]oxyethyl-trimethylazanium
lithocholic acid 24-O-(beta-D-glucuronide)
A steroid glucosiduronic acid obtained by formal condensation of the carboxy group of lithodeoxycholic acid with the anomeric hydroxy group of beta-D-glucuronic acid.
lithocholic acid 3-O-(beta-D-glucuronide)
A steroid glucosiduronic acid that is lithocholic acid having a single beta-D-glucuronic acid residue attached at position 3.
(1r,3s,4r,5r,7s)-4-methyl-1,3,7-tris(3-methylbut-2-en-1-yl)-4-(4-methylpent-3-en-1-yl)-5-(2-methylpropanoyl)-8-oxabicyclo[5.2.1]decane-6,9,10-trione
3,9,15-trimethyl-6,12-bis(2-methylpropyl)-18-(sec-butyl)-1,4,7,10,13,16-hexaazacyclooctadeca-1,4,7,10,13,16-hexaene-2,5,8,11,14,17-hexol
(1s,4r)-4-hydroxy-1-[(2r,5r)-5-[(2s)-2-hydroxy-6-methylhept-5-en-2-yl]-2-methyloxolan-2-yl]-4-[(2s,5r)-5-[(2s)-2-hydroxy-6-methylhept-5-en-2-yl]-2-methyloxolan-2-yl]butyl acetate
(1s,3s,4s,6s,7s,8r,11s,12s,14s,15r,16r)-4,6,14-trihydroxy-7,12,16-trimethyl-15-[(2s,5s)-2,5,6-trihydroxy-5-isopropylhexan-2-yl]pentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecane-7-carboxylic acid
5-(acetyloxy)-14-(butanoyloxy)-6,11-dihydroxy-3-isopropyl-6,10,14-trimethyl-15-oxatricyclo[6.6.1.0²,⁷]pentadec-9-en-4-yl butanoate
(1s,3s,8r,9r,10s)-3-(2-hydroxypropan-2-yl)-9-methyl-6,10-bis(3-methylbut-2-en-1-yl)-9-(4-methylpent-3-en-1-yl)-8-(2-methylpropanoyl)-4-oxatricyclo[6.3.1.0¹,⁵]dodec-5-ene-7,12-dione
(1s,3ar,3br,5ar,7r,9ar,9br,11ar)-1-[(2s,4r,5s)-4-chloro-5-hydroxy-5-(2-hydroxypropan-2-yl)-2-methyloxolan-2-yl]-3a,3b,6,6,9a-pentamethyl-dodecahydro-1h-cyclopenta[a]phenanthren-7-yl acetate
(4ar,5r,6as,6br,8ar,12ar,12br,14bs)-5-hydroxy-2,2,6a,6b,9,9,12a-heptamethyl-10-(sulfooxy)-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylic acid
18-(acetyloxy)-6-(furan-3-yl)-11-hydroxy-1,5,10,15-tetramethyl-13-oxapentacyclo[10.6.1.0²,¹⁰.0⁵,⁹.0¹⁵,¹⁹]nonadec-8-en-16-yl 2-methylbut-2-enoate
2-(dimethylamino)-3-phenyl-n-[5,8,11-trihydroxy-3-isopropyl-7-(2-methylpropyl)-2-oxa-6,9-diazabicyclo[10.2.2]hexadeca-1(14),5,8,12,15-pentaen-4-yl]propanimidic acid
2-{7-[3-(2,3-dihydroxypentan-2-yl)oxiran-2-yl]-6-methylhepta-2,4-dien-2-yl}-7,10-dihydroxy-3,7-dimethyl-12-oxo-1-oxacyclododec-4-en-6-yl acetate
(28e)-28,37-diethylidene-8,14,24,30-tetraazaundecacyclo[25.5.2.2¹¹,¹⁴.1¹,⁸.1¹⁰,¹⁷.0²,⁷.0¹³,¹⁷.0¹⁸,²³.0³⁰,³³.0²⁴,³⁵.0²⁶,³⁸]octatriaconta-2,4,6,9,18,20,22,25-octaene
4-(2-hydroxypropan-2-yl)-9-methyl-1,10-bis(3-methylbut-2-en-1-yl)-9-(4-methylpent-3-en-1-yl)-8-(2-methylpropanoyl)-3-oxatricyclo[6.3.1.0²,⁶]dodec-2(6)-ene-7,12-dione
6-{3a,7-dihydroxy-9a,11a-dimethyl-5-oxo-1h,2h,3h,5ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl}-5-hydroxy-2-methylheptan-2-yl benzoate
8-hydroxyhyperforin-8,1-hemiacetal
{"Ingredient_id": "HBIN013780","Ingredient_name": "8-hydroxyhyperforin-8,1-hemiacetal","Alias": "NA","Ingredient_formula": "C35H52O5","Ingredient_Smile": "CC(C)C(=O)C12C(=O)C3(C(=O)C(C1(O3)O)(CC(C2(C)CCC=C(C)C)CC=C(C)C)CC=C(C)C)CC=C(C)C","Ingredient_weight": "552.8 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "10218","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "129316606","DrugBank_id": "NA"}